KRAS G12C inhibitor 60
KRAS G12C inhibitor 60 (compound 23) is a Kras-G12C inhibitor. KRAS G12C inhibitor 60 can be used for the research of lung cancer, colorectal cancer, pancreatic cancer[1].
Product Specifications
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-60.html
Solubility
10 mM in DMSO
Smiles
FC1=CC2=C(N=C1C3=C(F)C=CC=C3N)N(C4=C([C@@H](C(F)(F)F)C)N=CC=C4C)C(N=C2N5C[C@@H](C)N(C(C=C)=O)C[C@@H]5C)=O
Molecular Formula
C31H30F5N7O2
Molecular Weight
627.61
References & Citations
[1]Yingli Z, et, a l. Heterocyclic compounds as Kras-G12C inhibitors. CN112574199B.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470669-100 1x 100 µL
P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC550525-100 1x 100 µL
CD63 (MX-49.129.5), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC700745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681857-100 1x 100 µL
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742147-100 1x 100 µL
Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 